Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Transfusion|September 9, 2021
A novel competition ELISA for the rapid quantification of SARS-CoV-2 neutralizing antibodies in convalescent plasmaElise Wouters, Caro Verbrugghe, Rosalie Devloo, et al.
Vox Sanguinis|March 16, 2023
An international comparison of haemoglobin deferral prediction models for blood bankingMarieke Vinkenoog, Jarkko Toivonen, Tinus Brits, et al.
Vox Sanguinis|April 18, 2024
Predicting haemoglobin deferral using machine learning models: Can we use the same prediction model across countries?Amber Meulenbeld, Jarkko Toivonen, Marieke Vinkenoog, et al.
Transfusion|April 5, 2017
Phylogenetic evidence for underreporting of male-to-male sex among human immunodeficiency virus-infected donors in the Netherlands and FlandersThijs J van de Laar, Daniela Bezemer, Kristel van Laethem, et al.
Nature Medicine|June 8, 2002
Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature miceVeerle Compernolle, Koen Brusselmans, Till Acker, et al.
Journal of the American Society of Nephrology : JASN|August 9, 2020
Eplet Mismatch Load and <i>De Novo</i> Occurrence of Donor-Specific Anti-HLA Antibodies, Rejection, and Graft Failure after Kidney Transplantation: An Observational Cohort StudyAleksandar Senev, Maarten Coemans, Evelyne Lerut, et al.
Nature Medicine|July 2, 2002
Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1Aernout Luttun, Marc Tjwa, Lieve Moons, et al.
Trials|November 28, 2020
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trialTimothy Devos, Tatjana Geukens, Alexander Schauwvlieghe, et al.
The European Respiratory Journal|August 27, 2021
Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasmaTimothy Devos, Quentin Van Thillo, Veerle Compernolle, et al.
Blood Transfusion = Trasfusione Del Sangue|December 18, 2019
Pathogen reduction of blood components during outbreaks of infectious diseases in the European Union: an expert opinion from the European Centre for Disease Prevention and Control consultation meetingDragoslav Domanović, Ines Ushiro-Lumb, Veerle Compernolle, et al.
Pageof 8